Pathophysiology of paraprotein production

Renal Failure

Volumn 20, Issue 6, 1998, Pages 821-828

  Maniatis, Alice ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Immunoglobulins; Monoclonal proteins; Plasma cell dyscrasias

Indexed keywords

PARAPROTEIN;

ACROCYANOSIS; AMYLOIDOSIS; B LYMPHOCYTE; BLOOD VISCOSITY; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; GAMMOPATHY; HEMOLYSIS; HUMAN; IMMUNOGLOBULIN PRODUCTION; KIDNEY DISEASE; PARAPROTEINEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031740257     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045179     Document Type: Conference Paper

References (35)

1. Staudt LM, Lenardo MJ: Immunoglobulin gene transcription. Annu Rev Immunol 9:373, 1991.
2. Andre-Schwartz J, Schwartz RS: Structure and function of the immune system In: Hoffman R, Benz EJJr, Shattil SJ, Furie R, Cohen HJ, Silberstein LE (eds); Hematology, Basic Principles and Practice. Churchill Livingston Inc, 1995, pp 86-108.
3. Snapper CM, Mond JJ: Towards a comprehensive view of immunoglobulin class switching. Immunol Today 14:15, 1993.
4. Lustermans AT, Klein F: Two cases of monoclonal immunoglobulins with antistreptolysin activity: Clinical and laboratory study. J. Clin Pathol 30:851, 1977.
5. Potter M., Boyce CR: Induction of plasma cell neoplasms in BALB-C mice with mineral oil and mineral oil adjuvants. Nature (Lond) 193:1086, 1962.
6. Potter M: Concepts of pathogenesis and experimental models of immunoglobulin secreting tumors in animals. In: Wieznik PH et al (ed); Neoplastic Diseases of Blood. Vol 1 Churchill Livingston, New York: 1985.
7. Osserman EF, Takatsuki K: Considerations regarding the pathogenesis of the plasmacytic dyscrasias. Scand J Haematol (suppl) 4:28, 1964.
8. Riedel DA, Pottem LN: The epidemiology of multiple myeloma. Hematol Oncol Clin North Am 6:225, 1992.
9. Zawadski ZA, Edwards GA: Dysimmunoglobulinemia in the absence of clinical features of multiple myeloma and macroglobulinemia. Am J Med 42:67, 1967.
10. Kyle RA, Lust JA: Monoclonal gammopathies of undetermined significance. Semin Hematol 1989; 26:176.
11. Blade J., Kyle RA. Monoclonal gammopathies of undetermined significance. In: Malpas JS, Bergragel DE, Kyle RA, (eds): Myeloma: Biology and Management. Oxford University Press, New York, 1995, pp 433-462.
12. Hallek M, Bergsagel PL, Andersen KC: Multiple Myeloma: Increasing evidence for a multistep transformation. Blood 91:3, 1998.
13. Feinman R, Sawyer J, Hardin J, Tricot G: Cytogenetics and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am 11:1, 1997.
14. Kyle RA: Monoclonal gammopathy of undetermined significance and Solitary Plasmacytoma. Implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am 11:71, 1997.
15. Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719, 1987.
16. Crawford J, Cox EB, Cohen HJ: Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 79:13, 1985.
17. Varticovski L, Pick AL, Schattner A, Shoenfeld Y: Anti-platelet and anti-DNA IgM in Waldenstrom's Macroglobulinemia and ITP. Am J Hematol 24:351, 1987.
18. Hory B, Saunier F, Wolff R et al: Waldenstrom's macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron 45:68, 1987.
19. Brouet JC, Clauvel JP, Danon F, Klein M, Seligman M et al: Biological and clinical significance of cryoglobulins. Am J Med 57:775, 1974.
20. Schubothe H: The cold hemagglutinin disease. Semin Hematol 3:27, 1966.
21. Crisp D, Pruzanski W: B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med 72:915, 1982.
22. Umlas J et al: A cryoglobulin with cold agglutinin and erythroid stem cell suppressant properties. Transfusion 31:361, 1991.
23. Kyle RA: Dysproteinemias and cryoglobulinemia. Curz Opin Rheumatol 1:221, 1989.
24. Parkins H, MacKenzie MR, Fudenberg HH: Hemostatic defects in dysproteinemias. Blood 35:695, 1970.
25. Pruzanski W, Shumak H: Biologic activity of cold reactive autoantibodies. N Engl J Med 297:536, 1977.
26. Buxbaum J. Mechanisms of disease: Monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am 6:323, 1992.
27. Solomon A, Weiss DT, Katine M: Nephrotoxic potential of Bence Jones proteins. N Engl J Med 324:1845, 1991.
28. Dhodapkar MV, Merlini G, Solomon A: Biology and Therapy of immunoglobulin deposition diseases. Hematol Oncol Clin North Am 11: 89, 1997.
29. Helms LR, Wetzel R: Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. J Mol Biol 255: 77, 1996.
30. Solomon A: Light chains of immunoglobulins: Structural - genetic correlates. Blood 68:603, 1986.
31. Solomon A: Clinical implications of monoclonal light chains. Semin Oncol 13:341, 1986.
32. Kyle RA, Gertz MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semm Hematol 32:45, 1995.
33. Sanders PW, Herresa GA: Monoclonal immunoglobulin light chain related renal diseases. Semin Nephrol 13:324, 1993.
34. Rosen SM et al: The structure of immunoglobulins and their genes, DNA rearrangement and B-cell differentiation, molecular anomalies and some monoclonal immunoglobulins. Semin Oncol 13:280, 1986.
35. Seligman M et al: Heavy chain diseases: Current findings and concepts. Immunol Rev 48:145, 1979.